This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Elrick, L. L.
Right arrow Articles by Berget, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Elrick, L. L.
Right arrow Articles by Berget, S. M.

 Previous Article  |  Next Article 

Mol. Cell. Biol., Jan 1998, 343-352, Vol 18, No. 1
Copyright © 1998, American Society for Microbiology

A short sequence within two purine-rich enhancers determines 5' splice site specificity

LL Elrick, MB Humphrey, TA Cooper and SM Berget
Verna and Marrs McLean Department of Biochemistry, Baylor College of Medicine, Houston, Texas 77030, USA.

Purine-rich enhancers are exon sequences that promote inclusion of alternative exons, usually via activation of weak upstream 3' splice sites. A recently described purine-rich enhancer from the caldesmon gene has an additional activity by which it directs selection of competing 5' splice sites within an alternative exon. In this study, we have compared the caldesmon enhancer with another purine-rich enhancer from the chicken cardiac troponin T (cTNT) gene for the ability to regulate flanking splice sites. Although similar in sequence and length, the two enhancers demonstrated strikingly different specificities towards 5' splice site choice when placed between competing 5' splice sites in an internal exon. The 32-nucleotide caldesmon enhancer caused effective usage of the exon-internal 5' splice site, whereas the 30-nucleotide cTNT enhancer caused effective usage of the exon-terminal 5' splice site. Both enhancer-mediated splicing pathways represented modulation of the default pathway in which both 5' splice sites were utilized. Each enhancer is multipartite, consisting of two purine-rich sequences of a simple (GAR)n repeat interdigitated with two enhancer-specific sequences. The entire enhancer was necessary for maximal splice site selectivity; however, a 5- to 7-nucleotide region from the 3' end of each enhancer dictated splice site selectivity. Mutations that interchanged this short region of the two enhancers switched specificity. The portion of the cTNT enhancer determinative for 5' splice site selectivity was different than that shown to be maximally important for activation of a 3' splice site, suggesting that enhancer environment can have a major impact on activity. These results are the first indication that individual purine-rich enhancers can differentiate between flanking splice sites. Furthermore, localization of the specificity of splice site choice to a short region within both enhancers indicates that subtle differences in enhancer sequence can have profound effects on the splicing pathway.


This article has been cited by other articles:

  • Wang, E., Dimova, N., Cambi, F. (2007). PLP/DM20 ratio is regulated by hnRNPH and F and a novel G-rich enhancer in oligodendrocytes. Nucleic Acids Res 0: gkm387v1-15 [Abstract] [Full Text]  
  • Tyson-Capper, A. J., Bailey, J., Krainer, A. R., Robson, S. C., Europe-Finner, G. N. (2005). The Switch in Alternative Splicing of Cyclic AMP-response Element Modulator Protein CREM{tau}2{alpha} (Activator) to CREM{alpha} (Repressor) in Human Myometrial Cells Is Mediated by SRp40. J. Biol. Chem. 280: 34521-34529 [Abstract] [Full Text]  
  • Lam, B. J., Bakshi, A., Ekinci, F. Y., Webb, J., Graveley, B. R., Hertel, K. J. (2003). Enhancer-dependent 5'-Splice Site Control of fruitless Pre-mRNA Splicing. J. Biol. Chem. 278: 22740-22747 [Abstract] [Full Text]  
  • Simard, M. J., Chabot, B. (2002). SRp30c Is a Repressor of 3' Splice Site Utilization. Mol. Cell. Biol. 22: 4001-4010 [Abstract] [Full Text]  
  • Biesiadecki, B. J., Jin, J.-P. (2002). Exon Skipping in Cardiac Troponin T of Turkeys with Inherited Dilated Cardiomyopathy. J. Biol. Chem. 277: 18459-18468 [Abstract] [Full Text]  
  • Pollard, A. J., Krainer, A. R., Robson, S. C., Europe-Finner, G. N. (2002). Alternative Splicing of the Adenylyl Cyclase Stimulatory G-protein Galpha s Is Regulated by SF2/ASF and Heterogeneous Nuclear Ribonucleoprotein A1 (hnRNPA1) and Involves the Use of an Unusual TG 3'-Splice Site. J. Biol. Chem. 277: 15241-15251 [Abstract] [Full Text]  
  • Romano, M., Marcucci, R., Baralle, F. E. (2001). Splicing of constitutive upstream introns is essential for the recognition of intra-exonic suboptimal splice sites in the thrombopoietin gene. Nucleic Acids Res 29: 886-894 [Abstract] [Full Text]  
  • McCullough, A. J., Berget, S. M. (2000). An Intronic Splicing Enhancer Binds U1 snRNPs To Enhance Splicing and Select 5' Splice Sites. Mol. Cell. Biol. 20: 9225-9235 [Abstract] [Full Text]  
  • Eperon, I. C., Makarova, O. V., Mayeda, A., Munroe, S. H., Cáceres, J. F., Hayward, D. G., Krainer, A. R. (2000). Selection of Alternative 5' Splice Sites: Role of U1 snRNP and Models for the Antagonistic Effects of SF2/ASF and hnRNP A1. Mol. Cell. Biol. 20: 8303-8318 [Abstract] [Full Text]  
  • Simard, M. J., Chabot, B. (2000). Control of hnRNP A1 Alternative Splicing: an Intron Element Represses Use of the Common 3' Splice Site. Mol. Cell. Biol. 20: 7353-7362 [Abstract] [Full Text]  
  • Bourgeois, C. F., Popielarz, M., Hildwein, G., Stevenin, J. (1999). Identification of a Bidirectional Splicing Enhancer: Differential Involvement of SR Proteins in 5' or 3' Splice Site Activation. Mol. Cell. Biol. 19: 7347-7356 [Abstract] [Full Text]  
  • Kuo, B. A., Norton, P. A. (1999). Accurate selection of a 5' splice site requires sequences within fibronectin alternative exon B. Nucleic Acids Res 27: 3945-3952 [Abstract] [Full Text]  
  • Labourier, E., Bourbon, H.-M., Gallouzi, I.-e., Fostier, M., Allemand, E., Tazi, J. (1999). Antagonism between RSF1 and SR proteins for both splice-site recognition in vitro and Drosophila development. Genes Dev. 13: 740-753 [Abstract] [Full Text]  
  • Schaal, T. D., Maniatis, T. (1999). Selection and Characterization of Pre-mRNA Splicing Enhancers: Identification of Novel SR Protein-Specific Enhancer Sequences. Mol. Cell. Biol. 19: 1705-1719 [Abstract] [Full Text]  
  • Cooper, T. A. (1998). Muscle-Specific Splicing of a Heterologous Exon Mediated by a Single Muscle-Specific Splicing Enhancer from the Cardiac Troponin T Gene. Mol. Cell. Biol. 18: 4519-4525 [Abstract] [Full Text]  
  • McNally, L. M., McNally, M. T. (1998). An RNA Splicing Enhancer-Like Sequence Is a Component of a Splicing Inhibitor Element from Rous Sarcoma Virus. Mol. Cell. Biol. 18: 3103-3111 [Abstract] [Full Text]  
  • Cote, J., Dupuis, S., Wu, J. Y. (2001). Polypyrimidine Track-binding Protein Binding Downstream of Caspase-2 Alternative Exon 9 Represses Its Inclusion. J. Biol. Chem. 276: 8535-8543 [Abstract] [Full Text]  
  • Lejeune, F., Cavaloc, Y., Stevenin, J. (2001). Alternative Splicing of Intron 3 of the Serine/Arginine-rich Protein 9G8 Gene. IDENTIFICATION OF FLANKING EXONIC SPLICING ENHANCERS AND INVOLVEMENT OF 9G8 AS A TRANS-ACTING FACTOR. J. Biol. Chem. 276: 7850-7858 [Abstract] [Full Text]  
  • Yousaf, N., Deng, Y., Kang, Y., Riedel, H. (2001). Four PSM/SH2-B Alternative Splice Variants and Their Differential Roles in Mitogenesis. J. Biol. Chem. 276: 40940-40948 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»